BridgeMD
Tests treatment safety and results for Intracerebral Haemorrhage
Official title Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage
ClinicalTrials.gov ID: NCT06894433
What this study is testing
- What it's testing
- This is a multicenter, randomized, controlled clinical trial comparing neuroendoscopic hematoma removal to craniotomy in the treatment of large intracerebral hemorrhage.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age 18-80 years old, male or female;
- The time between onset and admission to the first diagnostic CT is within 24 hours (for no bystanders and the time of onset is unknown, the time of...
- Patients with supratentorial intracerebral hemorrhage (supratentorial intracerebral hemorrhage (supratentorial intracerebral hemorrhage) whose...
- Before randomization, GCS score was 5-14, NIHSS score was ≥6;
- mRS Before onset: 0-1 score;
You likely can't join if
- The clinical diagnosis is caused by cerebral aneurysm, cerebrovascular malformation, moyamoya disease, brain trauma, brain tumor, massive cerebral...
- Thalamic hemorrhage, primary ventricular hemorrhage;
- Platelet count \ 1.4;
- Patients with advanced cerebral hernia (such as dilated bifidus and no light reflex) or unstable vital signs cannot tolerate surgery;
- Irreversible brain stem impairment (eye fixation, bilateral pupil dilation), GCS≤4 points;
- Any history of parenchyma or other intracranial subarachnoid, subdural or epidural blood and surgical history in the past 30 days;
See the full eligibility criteria
- Age 18-80 years old, male or female;
- The time between onset and admission to the first diagnostic CT is within 24 hours (for no bystanders and the time of onset is unknown, the time of the last known patient in good condition is used);
- Patients with supratentorial intracerebral hemorrhage (supratentorial intracerebral hemorrhage (supratentorial intracerebral hemorrhage) whose hematoma volume is ≥50ml or whose hematoma produces obvious space occupying...
- Before randomization, GCS score was 5-14, NIHSS score was ≥6;
- mRS Before onset: 0-1 score;
- Randomization within 24 hours after the first diagnostic CT;
- The patient or family members are informed and voluntarily sign the informed consent;
- The clinical diagnosis is caused by cerebral aneurysm, cerebrovascular malformation, moyamoya disease, brain trauma, brain tumor, massive cerebral infarction hemorrhage transformation, coagulation dysfunction, etc.;
- Thalamic hemorrhage, primary ventricular hemorrhage;
- Platelet count \ 1.4;
- Patients with advanced cerebral hernia (such as dilated bifidus and no light reflex) or unstable vital signs cannot tolerate surgery;
- Irreversible brain stem impairment (eye fixation, bilateral pupil dilation), GCS≤4 points;
- Any history of parenchyma or other intracranial subarachnoid, subdural or epidural blood and surgical history in the past 30 days;
- Patients with severe advanced cognitive impairment (such as AD) or who are not expected to complete the follow-up plan as required;
- Complicated with other serious diseases: including respiratory, circulation, digestion, urinary, endocrine, immune and blood systems;
- Pregnant or breastfeeding women, or those who expect to become pregnant within one year;
- are participating in other clinical trials (excluding: observational studies that do not involve intervention, natural history and/or epidemiological studies).
The study team makes the final eligibility decision.
Where it's taking place
- Chongqing, Chongqing Municipality, China
- Dazhou, Sichuan, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chongqing, Chongqing Municipality, China; Dazhou, Sichuan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.